PHARMACOKINETICS (PK) OF PROPYLENE GLYCOL-FREE MELPHALAN HCL (PG-FREE MEL) IN MULTIPLE MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AHCT)

被引：0
|
作者：
Hari, P. [1 ]
Dhakal, B. [1 ]
D'souza, A. [1 ]
Thompson, R. [1 ]
Hamadani, M. [1 ]
Pasquini, M. [1 ]
Chhabra, S. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1523
引用
收藏
页码：621 / 621
页数：1
相关论文
共 50 条
  • [21] PHASE IIA, OPEN-LABEL, RANDOMIZED, PHARMACOKINETIC COMPARATIVE, CROSS-OVER STUDY OF MELPHALAN HCL FOR INJECTION (PROPYLENE GLYCOL-FREE) AND ALKERAN FOR INJECTION FOR MYELOABLATIVE CONDITIONING IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION
    Aljitawi, O. S.
    Ganguly, S.
    Abhyankar, S.
    Wolfe, K.
    Daniels, K.
    Ferree, M.
    Marks, R.
    Kramer, W.
    Pipkins, J. D.
    McGruirk, J. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S257 - S257
  • [22] Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective
    Badar, Talha
    Hari, Parameswaran
    Chhabra, Saurabh
    Dhakal, Binod
    Drobyski, William R.
    Fenske, Timothy S.
    Hamadani, Mehdi
    Pasquini, Marcelo
    Saber, Wael
    Shah, Nirav N.
    Shaw, Bronwen E.
    D'Souza, Anita
    BONE MARROW TRANSPLANTATION, 2018, 53 (09) : 1210 - 1213
  • [23] Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective
    Talha Badar
    Parameswaran Hari
    Saurabh Chhabra
    Binod Dhakal
    William R. Drobyski
    Timothy S. Fenske
    Mehdi Hamadani
    Marcelo Pasquini
    Wael Saber
    Nirav N. Shah
    Bronwen E. Shaw
    Anita D’Souza
    Bone Marrow Transplantation, 2018, 53 : 1210 - 1213
  • [24] Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)
    Shah, Gunjan L.
    Lin, Andrew
    Schofield, Ryan
    Sarubbi, Caitlin
    Preston, Elaina V.
    Devlin, Sean M.
    Bhatt, Valkal
    Harnicar, Stephen J.
    Hoover, Elizabeth
    Chung, David J.
    Dahi, Parastoo B.
    Koehne, Guenther
    Tamari, Roni
    Carlow, Dean
    Giralt, Sergio A.
    Landau, Heather
    BLOOD, 2017, 130
  • [25] Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study
    Sarosiek, Shayna
    Sloan, John Mark
    Quillen, Karen
    Brauneis, Dina
    Cruz, Ramon
    Schulman, Amanda
    Fennessey, Salli
    Shelton, Anthony
    Sanchorawala, Vaishali
    BLOOD, 2019, 134
  • [26] Use of Propylene Glycol-Free Melphalan Conditioning in Light Chain Amyloidosis Patients Undergoing Autologous Hematopoietic Cell Transplantation is Associated with Significantly Lower Hospitalization Days
    Badar, Talha
    Hari, Parameswaran
    Chhabra, Saurabh
    Dhakal, Binod
    Drobyski, William R.
    Fenske, Timothy S.
    Hamadani, Mehdi
    Pasquini, Marcelo C.
    Rizzo, J. Douglas
    Saber, Wael
    Shah, Nirav
    Shaw, Bronwen E.
    D'Souza, Anita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S134 - S135
  • [27] Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Cashen, Amanda F.
    Fletcher, Theresa
    Ceriotti, Connie
    Gao, Feng
    Ghobadi, Armin
    Vij, Ravi
    Stockerl-Goldstein, Keith
    DiPersio, John
    Abboud, Camille
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2155 - 2158
  • [28] A Phase lib, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
    Hari, Parameswaran
    Aljitawi, Omar S.
    Arce-Lara, Carlos
    Nath, Rajneesh
    Callander, Natalie
    Bhat, Gajanan
    Allen, Lee F.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2100 - 2105
  • [29] Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Cashen, Amanda F.
    Gosch, Kendall
    Fletcher, Theresa
    Ceriotti, Connie
    Ghobadi, Armin
    Vij, Ravi
    Stocker-Goldstein, Keith
    Dipersio, John F.
    Abboud, Camille N.
    BLOOD, 2015, 126 (23)
  • [30] Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)
    Cashen, Amanda
    Gosch, Kendall
    Fletcher, Theresa
    Ceriotti, Connie
    Ghobadi, Armin
    Vij, Ravi
    Stockerl-Goldstein, Keith
    DiPersio, John F.
    Abboud, Camille
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S67 - S67
12345